Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Versus Graft Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03190733
What this trial is testing

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Who this might be right for
Chronic Graft-versus-host-diseaseLeukemia Relapse
Zhujiang Hospital 192
Not applicableEnded earlyNCT03557749
What this trial is testing

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Who this might be right for
Immune and Microbial ReconstitutionSystemic Viral InfectionAcute-graft-versus-host Disease+5 more
Masonic Cancer Center, University of Minnesota 210
Testing effectiveness (Phase 2)Study completedNCT03604692
What this trial is testing

Evaluate Axatilimab in Participants With Active cGVHD

Who this might be right for
Chronic Graft-versus-host-disease
Syndax Pharmaceuticals 41
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00186667
What this trial is testing

Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

Who this might be right for
Graft vs Host DiseaseBlood and Marrow Transplant (BMT)
Stanford University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Testing effectiveness (Phase 2)Study completedNCT00343785
What this trial is testing

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Who this might be right for
Aplastic Anemia
Fred Hutchinson Cancer Center 21
Large-scale testing (Phase 3)Study completedNCT01951885
What this trial is testing

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more
Case Comprehensive Cancer Center 101
Testing effectiveness (Phase 2)Looking for participantsNCT07124078
What this trial is testing

Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

Who this might be right for
Chronic Graft-versus-host-disease
Incyte Corporation 60
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06186804
What this trial is testing

A Phase II Study Evaluating the Efficacy and Safety of ABSK021 (Pimicotinib)) in the Treatment of cGvHD Chronic Graft Versus Host Disease (cGvHD)

Who this might be right for
cGvHD
Abbisko Therapeutics Co, Ltd 64
Not applicableStudy completedNCT02519621
What this trial is testing

NPWT PRO vs KCI Ulta® NPWT and to Compare NPWT PRO vs NPWT PRO With Simultaneous Irrigation on Wound Healing

Who this might be right for
Partial-thickness BurnUlcer
Larry Lavery 90
Testing effectiveness (Phase 2)Study completedNCT00054613
What this trial is testing

Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease

Who this might be right for
Graft-versus-Host Disease
Mallinckrodt 72
Testing effectiveness (Phase 2)Ended earlyNCT02877082
What this trial is testing

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Who this might be right for
Acute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more
Emory University 5
Testing effectiveness (Phase 2)Study completedNCT00346359
What this trial is testing

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Testing effectiveness (Phase 2)Study completedNCT02891395
What this trial is testing

Efficacy and Safety of Nilotinib in Patients With a Chronic Disease of the Graft Against the Host

Who this might be right for
Graft Versus Host Disease
University Hospital, Lille 65
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Large-scale testing (Phase 3)Study completedNCT00210912
What this trial is testing

The Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 328
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page
35